| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.22B | +12.9% |
| Cost of Revenue | $717.4M | +23.6% |
| R&D Expense | $921.9M | +23.4% |
| SG&A Expense | $1.15B | +14.3% |
| Operating Income | $409.5M | -15.4% |
| Pre-tax Income | $482.5M | -10.9% |
| Income Tax | $133.6M | +16.3% |
| Net Income | $348.9M | -18.3% |
| EPS (Basic) | $1.82 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.31B | +39.1% |
| Accounts Receivable | $908.2M | +37.5% |
| Inventory | $1.30B | +5.4% |
| Current Assets | $3.95B | +22.3% |
| Total Assets | $7.59B | +8.7% |
| Current Liabilities | $759.0M | +25.0% |
| Total Liabilities | $1.51B | +13.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $828.0M | +44.5% |
| Capital Expenditures | $103.0M | +20.6% |
| Investing Cash Flow | -$414.2M | -403.5% |
| Financing Cash Flow | -$42.4M | +91.9% |
| Free Cash Flow | $725.0M | +48.7% |
| -19.1% |
| EPS (Diluted) | $1.80 | -18.6% |
| Stockholders' Equity |
| $6.09B |
| +7.6% |